2020
110 RNA expression analysis in stage IVA-B cutaneous T-cell lymphoma to identify novel biomarkers of prognosis and diagnosis
Mirza F, Yumeen S, Lewis J, King A, Kim S, Carlson K, Foss F, Girardi M. 110 RNA expression analysis in stage IVA-B cutaneous T-cell lymphoma to identify novel biomarkers of prognosis and diagnosis. Journal Of Investigative Dermatology 2020, 140: s13. DOI: 10.1016/j.jid.2020.03.113.Peer-Reviewed Original Research
2011
Nephrogenic systemic fibrosis: Clinicopathological definition and workup recommendations
Girardi M, Kay J, Elston DM, LeBoit PE, Abu-Alfa A, Cowper SE. Nephrogenic systemic fibrosis: Clinicopathological definition and workup recommendations. Journal Of The American Academy Of Dermatology 2011, 65: 1095-1106.e7. PMID: 21724294, DOI: 10.1016/j.jaad.2010.08.041.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsDiagnosis of NSFNephrogenic systemic fibrosisClinicopathological definitionNSF diagnosisWorkup recommendationsPrior clinical experienceClinicopathological presentationRenal diseaseHistopathological featuresRisk factorsStudy populationPrecise causationSystemic fibrosisClinical experienceAccurate diagnosisClinical expertiseDiagnostic standardHistopathological atlasDiagnosisGold standardMedical investigationsCompelling associationPhysiciansIndisputable linkContrast agents
2008
Nephrogenic Systemic Fibrosis: A Dermatologist’s Perspective
Girardi M. Nephrogenic Systemic Fibrosis: A Dermatologist’s Perspective. Journal Of The American College Of Radiology 2008, 5: 40-44. PMID: 18180008, DOI: 10.1016/j.jacr.2007.08.017.Peer-Reviewed Original ResearchConceptsNephrogenic systemic fibrosisSystemic fibrosisDermatologist's perspectiveCutaneous manifestationsExtracorporeal photopheresisSevere contracturesSkin findingsCutaneous lesionsSubcutaneous indurationDiagnostic confirmationDifferential diagnosisSuch lesionsFibrosisLesionsPhotopheresisPatientsContracturePapulesPathogenesisIndurationPlaquesDiagnosis